Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
View all
Veracyte
Post IPO Equity • South San Francisco, United States
Sage Therapeutics
Post IPO Equity • Cambridge, United States
Insmed
Post IPO Equity • Bridgewater, United States
Aimmune Therapeutics
Post IPO Equity • Brisbane, United States
Atara Biotherapeutics
Post IPO Equity • South San Francisco, United States
Biohaven Pharmaceuticals
Post IPO Equity • New Haven, United States
Standard BioTools
Post IPO Equity • South San Francisco, United States
Sema4
Post IPO Equity • Stamford, United States
NeoGenomics
Post IPO Equity • Fort Myers, United States
Ultragenyx Pharmaceutical
Post IPO Equity • Novato, United States
NanoString
Post IPO Equity • Seattle, United States
Legend Biotech
Post IPO Equity • Piscataway, United States